Hospital-based and independent labs are increasingly challenged by depressed volume, declining payment rates, and market disruptions. Projected losses for public lab companies were offset in Q1 2018 by increased M&A activity, strong results across core lab products and services, and a severe flu season. Industry analysts project single-digit percentage revenue losses over the remaining months of 2018.

In a new M&A Snapshot, Kaufman Hall reviews, key trends, recent transaction activity, and strategic implications for the lab sector.